These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38261628)

  • 1. Patient burden and joint inflammation during development of RA from arthralgia: is it similar in ACPA-positive and ACPA-negative disease?
    Khidir SJH; Krijbolder DI; Glas HK; van Mulligen E; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2024 Sep; 63(9):2336-2344. PubMed ID: 38261628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence of joint tissue inflammation during rheumatoid arthritis development.
    Ten Brinck RM; van Steenbergen HW; van der Helm-van Mil AHM
    Arthritis Res Ther; 2018 Nov; 20(1):260. PubMed ID: 30463603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint involvement in RA starts predominantly in the hands: functional, clinical and imaging studies in clinically suspect arthralgia and during progression to RA.
    Khidir SJH; van Dijk BT; Krijbolder DI; Verstappen M; van Mulligen E; van der Helm-van Mil AHM
    RMD Open; 2023 Jun; 9(2):. PubMed ID: 37328293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis.
    van Steenbergen HW; Mangnus L; Reijnierse M; Huizinga TW; van der Helm-van Mil AH
    Ann Rheum Dis; 2016 Oct; 75(10):1824-30. PubMed ID: 26613769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.
    Ten Brinck RM; van Steenbergen HW; van Delft MAM; Verheul MK; Toes REM; Trouw LA; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2017 Dec; 56(12):2145-2153. PubMed ID: 28968865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis.
    van Steenbergen HW; van Nies JA; Huizinga TW; Reijnierse M; van der Helm-van Mil AH
    Arthritis Res Ther; 2014 Apr; 16(2):R92. PubMed ID: 24721160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. During development of rheumatoid arthritis, intermetatarsal bursitis may occur before clinical joint swelling: a large imaging study in patients with clinically suspect arthralgia.
    van Dijk BT; Wouters F; van Mulligen E; Reijnierse M; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2022 Jul; 61(7):2805-2814. PubMed ID: 34791051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis.
    Wouters F; Maurits MP; van Boheemen L; Verstappen M; Mankia K; Matthijssen XME; Dorjée AL; Emery P; Knevel R; van Schaardenburg D; Toes REM; van der Helm-van Mil AHM
    Ann Rheum Dis; 2022 Jan; 81(1):48-55. PubMed ID: 34285049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The course of fatigue during the development of rheumatoid arthritis and its relation with inflammation: a longitudinal study.
    Khidir SJH; Wouters F; van der Helm-van Mil AHM; van Mulligen E
    Joint Bone Spine; 2022 Nov; 89(6):105432. PubMed ID: 35777555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forefoot inflammation in recent-onset ACPA-positive and ACPA-negative RA: clinically similar, but different in underlying inflamed tissues.
    Ton DA; van Dijk BT; van Steenbergen HW; van der Helm-van Mil AHM
    RMD Open; 2024 Oct; 10(4):. PubMed ID: 39357927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia.
    Ten Brinck RM; Toes REM; van der Helm-van Mil AHM
    Arthritis Res Ther; 2018 May; 20(1):89. PubMed ID: 29720256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do magnetic resonance imaging-detected erosions predict progression to rheumatoid arthritis in patients presenting with clinically suspect arthralgia? A longitudinal study.
    Wouters F; Matthijssen X; Boeters DM; Ten Brinck RM; Van Der Helm-Van Mil A; Niemantsverdriet E
    Scand J Rheumatol; 2020 Nov; 49(6):461-467. PubMed ID: 32484376
    [No Abstract]   [Full Text] [Related]  

  • 13. Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.
    Boer AC; Boonen A; van der Helm van Mil AHM
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):987-996. PubMed ID: 29266813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morning stiffness precedes the development of rheumatoid arthritis and associates with systemic and subclinical joint inflammation in arthralgia patients.
    Krijbolder DI; Wouters F; van Mulligen E; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2022 May; 61(5):2113-2118. PubMed ID: 34401906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation.
    Verstappen M; Matthijssen XME; Connolly SE; Maldonado MA; Huizinga TWJ; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2022 Dec; 62(1):124-134. PubMed ID: 35583256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis.
    Shafrin J; Tebeka MG; Price K; Patel C; Michaud K
    J Manag Care Spec Pharm; 2018 Jan; 24(1):4-11. PubMed ID: 29290168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical synovitis in arthralgia: how often does it result in clinical arthritis? Reflecting on starting points for disease-modifying anti-rheumatic drug treatment.
    Rogier C; Wouters F; van Boheemen L; van Schaardenburg D; de Jong PHP; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2021 Aug; 60(8):3872-3878. PubMed ID: 33331633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Natural Sequence in Which Subclinical Inflamed Joint Tissues Subside or Progress to Rheumatoid Arthritis: A Study of Serial MRIs in the TREAT EARLIER Trial.
    Krijbolder DI; Matthijssen XME; van Dijk BT; van Steenbergen HW; Boeters DM; Willemze A; Schouffoer AA; van der Helm-van Mil AHM
    Arthritis Rheumatol; 2023 Sep; 75(9):1512-1521. PubMed ID: 37094363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of symptoms in clinically suspect arthralgia and resolution of subclinical joint inflammation: a longitudinal study in patients that did not progress to clinical arthritis.
    Ten Brinck RM; Boeters DM; van Steenbergen HW; van der Helm-van Mil AHM
    Arthritis Res Ther; 2020 Jan; 22(1):11. PubMed ID: 31948479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines).
    Westra J; Brouwer E; Raveling-Eelsing E; Arends S; Eman Abdulle A; Roozendaal C; van Delft MAM; Toes REM; Trouw LA; Vissink A; de Smit MJ
    Rheumatology (Oxford); 2021 Feb; 60(2):658-666. PubMed ID: 32594174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.